{
    "code": "02025055",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02025055",
    "time": "2020-02-25 13:30:56",
    "許可證字號": "衛署藥輸字第025055號",
    "註銷狀態": "已註銷",
    "註銷日期": "104\/06\/01",
    "註銷理由": "自請註銷",
    "有效日期": "103\/07\/22",
    "發證日期": "98\/07\/22",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202505503",
    "中文品名": "紫杉寧注射劑",
    "英文品名": "Docetaxel Winthrop Concentrate and Solvent for Solution for infusion",
    "適應症": "乳癌、非小細胞肺癌、前列腺癌、頭頸癌、胃腺癌。",
    "劑型": "270注射劑",
    "包裝": "20mg\/80mg小瓶 100支以下盒裝 各附等支數0.5ml\/2ml小瓶附溶液",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "05限由醫師使用",
    "藥品分類": "",
    "主製造廠": {
        "限制項目": "02輸　入 24監視期滿學名藥",
        "申請商名稱": "620101J834  溫莎藥品股份有限公司",
        "申請商地址": "台北市松山區復興北路337號12樓",
        "主製造廠": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1013000200",
            "成分名稱": "DOCETAXEL",
            "含量描述": "",
            "含量": "40.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "02025055___20111104.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025055&Seq=002&Type=9"
        }
    ]
}